Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report

By afschroeder • October 18, 2026

Morris B. Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report. Cureus. 2026 Sep 15;18(9):e116307. doi: 10.7759/cureus.116307. PMID: 42890326; PMCID: PMC13671583.

Tags: General Internal Medicine, glp-1 agonist, glucagon-like-peptide-1, habit making, medical weight loss, Primary Care, Publications, weight loss and behavior, weight reduction

Susan Ettner, PhD and Dennis J. Slamon, MD, PhD Elected to the National Academy of Medicine

The UCLA Department of Medicine (DoM) is pleased to congratulate Susan Ettner, PhD and Dennis Slamon, MD, PhD, on their election to the National Academy[...]

From discovery to preparedness: reframing antimicrobial resistance as a global governance challenge

Nguyen QK, Mayne JD, Taylor-Robinson AW. From discovery to preparedness: reframing antimicrobial resistance as a global governance challenge. Front Public Health. 2026 Oct 1;14:1965508. doi:[...]

Invasive Cryptococcal Meningitis: A Sequelae of Primary Intestinal Lymphangiectasia

Kwon J, Wang HL, Weiss GA, Myint A. Invasive Cryptococcal Meningitis: A Sequelae of Primary Intestinal Lymphangiectasia. ACG Case Rep J. 2026 Oct 14;13(10):e02360. doi:[...]